文献速递生殖医学

首次冻胚移植后生化或临床妊娠丢失不影响后续移植结局

Biochemical or clinical pregnancy loss after first embryo transfer does not affect subsequent transfer outcome.
PubMed 文献 · Reprod Biomed Online · 2025-12-19

该回顾性队列研究纳入2017年1月至2021年12月间在大学附属生殖中心连续两次单胚胎冻胚移植(FET)的患者,比较首次FET后发生生化或临床妊娠丢失者与首次移植失败者在第二次FET中的妊娠丢失率。在2103例连续两次整倍体FET患者中,首次生化丢失后第二次生化丢失率为9.9%、临床丢失率为10.5%,与既往移植失败者(9.6%,P=0.890;10.9%,P=0.556)无显著差异;首次临床丢失者第二次生化及临床丢失率亦与移植失败者相当(11.5% vs 9.6%,P=0.272;12.5% vs 10.9%,P=0.456)。在282例未检测胚胎FET中结果一致。结论认为整倍体或未检测FET后生化或临床妊娠丢失不增加后续移植妊娠丢失风险。

要点

  • 首次整倍体FET后生化丢失者第二次生化丢失率9.9%,与移植失败者9.6%无显著差异(P=0.890)。
  • 首次整倍体FET后临床丢失者第二次临床丢失率12.5%,与移植失败者10.9%无显著差异(P=0.456)。
  • 未检测胚胎FET中既往妊娠丢失与移植失败者的后续丢失率亦无显著差异。

核心结论

  • 整倍体或未检测FET后发生生化或临床妊娠丢失,不增加后续冻胚移植的妊娠丢失风险。

研究设计与样本

  • 回顾性队列研究,纳入2017年1月至2021年12月在大学附属生殖中心连续两次单胚胎冻胚移植的患者。
  • 比较首次FET后生化或临床妊娠丢失者与首次FET移植失败者在第二次FET中的妊娠丢失率。
  • 整倍体FET分析人群2103例,未检测胚胎FET分析人群282例。

主要发现

  • 首次整倍体FET生化丢失后,第二次FET生化丢失率9.9%、临床丢失率10.5%。
  • 既往移植失败者第二次FET生化丢失率9.6%(P=0.890)、临床丢失率10.9%(P=0.556)。
  • 首次整倍体FET临床丢失后,第二次FET生化丢失率11.5% vs 移植失败者9.6%(P=0.272),临床丢失率12.5% vs 10.9%(P=0.456)。
  • 未检测胚胎FET(n=282)中,既往妊娠丢失与移植失败者的后续妊娠丢失率无显著差异。

临床怎么用

  • 对于首次FET后发生生化或临床妊娠丢失的患者,后续移植决策可不必因既往妊娠丢失而过度担忧妊娠丢失风险增加。

局限性

  • 回顾性研究设计,可能存在选择偏倚和混杂因素。
  • 未检测胚胎分析样本量较小(n=282),结果解释需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does biochemical or clinical pregnancy loss after frozen embryo transfer (FET) increase the odds of pregnancy loss in a subsequent transfer? DESIGN: Retrospective cohort study evaluating patients who underwent two consecutive single FETs using either euploid or untested embryos at a university-affiliated fertility centre between January 2017 and December 2021. Patients who had experienced a biochemical or clinical pregnancy loss after the first FET were compared with those who had experienced implantation failure in the subsequent FET. RESULTS: Among 2103 patients who underwent two consecutive euploid FETs, those who had experienced a biochemical loss after their first euploid FET had a subsequent biochemical loss rate of 9.9% and a clinical loss rate of 10.5% in their second euploid FET. These rates did not significantly differ from those who had experienced previous implantation failure (9.6%, P = 0.890; 10.9%, P = 0.556, respectively). Similarly, among patients who had experienced a clinical loss in their first euploid FET, rates of biochemical and clinical loss in the second euploid transfer were comparable to those who had experienced previous implantation failure (11.5% versus 9.6%, P = 0.272; and 12.5% versus 10.9%, P = 0.456, respectively). These findings remained consistent when analysing untested (n = 282) FETs, with no significant differences in subsequent pregnancy loss rates between patients who had experienced previous pregnancy loss and those who had experienced implantation failure. CONCLUSIONS: Biochemical or clinical pregnancy loss after a euploid or untested FET is not associated with an increased risk of pregnancy loss in the subsequent transfer.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Barrett F, Kalafat E, Vessa B, et al. Biochemical or clinical pregnancy loss after first embryo transfer does not affect subsequent transfer outcome. Reprod Biomed Online. 2025. PMID: 41819682. doi:10.1016/j.rbmo.2025.105435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。